Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
- Status
- COMPLETED
- Phase
- PHASE3
An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients
- Status
- COMPLETED
- Phase
- PHASE1
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults
- Status
- COMPLETED
- Phase
- PHASE1
Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders
- Status
- COMPLETED
- Phase
- PHASE3
Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
- Status
- COMPLETED
- Phase
- PHASE2